Funding global health product R&D: the Portfolio-To-Impact Model (P2I), a new tool for modelling the impact of different research portfolios [version 2; referees: 2 approved]
Background: The Portfolio-To-Impact (P2I) Model is a novel tool, developed to estimate minimum funding needs to accelerate health product development from late stage preclinical study to phase III clinical trials, and to visualize potential product launches over time. Methods: A mixed methods approa...
Main Authors: | Robert F Terry, Gavin Yamey, Ryoko Miyazaki-Krause, Alexander Gunn, John C. Reeder |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-07-01
|
Series: | Gates Open Research |
Online Access: | https://gatesopenresearch.org/articles/2-24/v2 |
Similar Items
-
Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool [version 2; peer review: 2 approved, 1 approved with reservations]
by: Alexander Gunn, et al.
Published: (2020-02-01) -
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 2; referees: 3 approved]
by: Ruth Young, et al.
Published: (2018-08-01) -
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 1; referees: 1 approved, 2 approved with reservations]
by: Ruth Young, et al.
Published: (2018-04-01) -
Analysis of the health product pipeline for poverty-related and neglected diseases using the Portfolio-to-Impact (P2I) modeling tool [version 1; peer review: 2 approved]
by: Alexander Gunn, et al.
Published: (2020-05-01) -
Sharing health research data – the role of funders in improving the impact [version 2; referees: 1 approved, 2 approved with reservations]
by: Robert F. Terry, et al.
Published: (2018-12-01)